| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.1M | +611.9% |
| R&D Expense | $65.3M | +81.6% |
| SG&A Expense | $16.6M | +70.3% |
| Operating Income | -$80.8M | -3995.1% |
| Pre-tax Income | -$72.3M | -1584.2% |
| Income Tax | -$498K | -172.1% |
| Net Income | -$71.8M | -1817.7% |
| EPS (Basic) | -$7.26 | -2603.4% |
| EPS (Diluted) | -$7.26 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $238.2M | +169.2% |
| Short-term Investments | $112.7M | — |
| Accounts Receivable | $171K | +13.2% |
| Current Assets | $356.8M | +216.7% |
| Total Assets | $456.6M | +248.9% |
| Current Liabilities | $12.8M | +85.8% |
| Total Liabilities | $36.5M | +82.3% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$67.5M | -74.2% |
| Capital Expenditures | $2.1M | -26.9% |
| Investing Cash Flow | -$160.6M | -826.0% |
| Financing Cash Flow | $377.8M | +407.0% |
| Free Cash Flow | -$69.6M | -67.2% |
| -2603.4% |
| Stockholders' Equity |
| $420.0M |
| +1194.6% |